Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma

Name: Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
Published: 2009
License: Public Domain

M.D. Anderson Cancer Center · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

brain-cancer brain-tumor

brain cancer, pediatric cancers, brain tumor, recurrent ependymoma, refractory ependymoma, intracranial ependymoma, ependymoblastoma, subependymoma, myxopapillary, clear cell, anaplastic, bevacizumab

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 890824
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.